Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sherri Hawk"'
Publikováno v:
Mental Health Clinician. 5:169-173
Introduction: A previous study at Veterans Affairs (VA) Eastern Colorado Health Care System revealed low rates of compliance with VA Pharmacy Benefits Management Services recommendations for antipsychotic selection in schizophrenia and schizoaffectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20529ab0744c975f873c822450779e22
https://doi.org/10.9740/mhc.2015.07.169
https://doi.org/10.9740/mhc.2015.07.169
Autor:
Allan V. Prochazka, Elizabeth Cheng, Lisa A. Davis, Liron Caplan, Evelyn Hutt, Hannah R. Dischinger, Tiffany M. Grueber, Alyse Mann, Sherri Hawk
Publikováno v:
Journal of Evaluation in Clinical Practice. 21:614-619
RATIONALE, AIMS, AND OBJECTIVES Long-term exposure to glucocorticoids can cause adverse drug reactions of long latency (ADRLLs), including glucocorticoid-induced diabetes mellitus (GID). Providers can monitor for GID using the glycosylated haemoglobi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb0d8b5fbd39e002598cf3034a47f03c
https://doi.org/10.1111/jep.12351
https://doi.org/10.1111/jep.12351
Publikováno v:
Mental Health Clinician. 3:188-192
Introduction: In 2012, the Veterans Affairs (VA) Pharmacy Benefits Management Services created recommendations for antipsychotic selection in schizophrenia and schizoaffective disorders. The recommendations stated that patients must fail two first li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dc9c7bd05dc7c6da121dbbe3a42fb87
https://doi.org/10.9740/mhc.n172352
https://doi.org/10.9740/mhc.n172352
Autor:
Hannah R, Dischinger, Elizabeth, Cheng, Alyse D, Mann, Tiffany M, Grueber, Sherri, Hawk, Lisa A, Davis, Allan V, Prochazka, Evelyn, Hutt, Liron, Caplan
Publikováno v:
Journal of evaluation in clinical practice. 21(4)
Long-term exposure to glucocorticoids can cause adverse drug reactions of long latency (ADRLLs), including glucocorticoid-induced diabetes mellitus (GID). Providers can monitor for GID using the glycosylated haemoglobin blood (HbA1C) test. This study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c7194018e2fcc0abbb8a2094467d1b93
https://pubmed.ncbi.nlm.nih.gov/25851076
https://pubmed.ncbi.nlm.nih.gov/25851076